Ken Blount

Chief Scientific Officer, Rebiotix and VP Microbiome Research, Ferring Pharmaceuticals

Role
Board Member at Microbiome Therapeutics Innovation Group
Location
Guilford, CT, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Ken Blount

As a recognized world leader in Microbiome Pharmaceutical Development, I have led, guided, and collaborated to drive success for multiple therapeutics entities-from Phase 2 through approval and launch, from ideation to IND and first-in-human, from phase 1 to end-of-Phase 2 meetings. I\'ve led CMC development and submission, investigator-sponsored clinical trials programs, evidence generation for field medical and commercial, and beyond.I\'ve been a key leader and driver for the establishing the microbiome therapeutics industry, including chairing the Microbiome Therapeutics Innovation Group, participating in the Public Advisory Committee for the first FDA-approved microbiota-based therapeutic, serving on the advisory board for multiple biotech companies and microbiome therapeutics conferences.

Experience

  1. Board Member

    Microbiome Therapeutics Innovation Group

    Jun 2022 — Present

Education

  • Harvard Business School Online

    Certificate of Completion, Organizational Leadership

  • Harvard Business School Online

    Certificate in Power and Influence for Positive Impact

  • University of Arkansas

    BS, Chemistry

    1990 — 1994

  • University of Colorado Boulder

    Doctor of Philosophy (Ph.D.), Biochemistry

    1995 — 2001

  • Harvard Business School Online

    Certificate in Negotiation Mastery

    2021 — 2021

Skills

  • Translational Medicine
  • CRO Management
  • Translational Research
  • Drug Discovery
  • Research Management
  • Drug Development
  • Grant Writing
  • Biotechnology
  • Protein Purification
  • Research and Development (R
  • High Throughput Screening
  • Clinical Microbiology
  • In Vitro
  • Collaborative Leadership
  • Antibiotic Resistance
  • Protein Chemistry
  • Lifesciences
  • Assay Development
  • Antibacterial
  • Anaerobic Microbiology
  • Life Sciences
  • Pcr
  • Pharmaceutical Industry
  • Fundraising
  • Polymerase Chain Reaction (Pcr)
  • Early-Stage Startups
  • Biochemistry
  • Infectious Diseases
  • Microbiology
  • Science
  • Molecular Biology
  • Venture Capital
  • Rna
  • Cell Biology
  • Oncology
  • Cell Culture

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Ken Blount — Board Member at Microbiome Therapeutics Innovation Group in Guilford, CT, US | Unifers